Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human Limbal Epithelial Cells in Vitro

Topical application of vascular endothelial growth factor A (VEGFA) inhibitors including Bevacizumab is used for antiangiogenic therapy at the ocular surface. While clinical studies have suggested that this approach is well-tolerated, the effect of the drug on limbal epithelial stem cells has not be...

Descripción completa

Detalles Bibliográficos
Autores principales: Notara, Maria, Lentzsch, Anna, Clahsen, Thomas, Behboudifard, Sara, Braun, Gabriele, Cursiefen, Claus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912829/
https://www.ncbi.nlm.nih.gov/pubmed/31717500
http://dx.doi.org/10.3390/jcm8111925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912829/
https://www.ncbi.nlm.nih.gov/pubmed/31717500
http://dx.doi.org/10.3390/jcm8111925

Ejemplares similares